MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Reduction in battery longevity for each subsequent implantable pulse generator (IPG) in patients with Parkinson’s disease (PD) treated with bilateral subthalamic nucleus deep brain stimulation (STN-DBS) may be due to both programming changes and IPG model – a case series

S.D. Israeli-Korn, S. Tessler, G. Yahalom, S. Benizri, O.S. Cohen, C. Shabat, H. Strauss, N. Warmann-Alaluf, E. Stein, Z. Zibly, R. Spiegelman, S. Hassin, S. Hassin (Ramat Gan, Israel)

Meeting: 2016 International Congress

Abstract Number: 111

Keywords: Deep brain stimulation (DBS), Parkinsonism, Subthalamic nucleus(SIN)

Session Information

Date: Monday, June 20, 2016

Session Title: Surgical therapy: Parkinson's disease

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To determine whether the decrease in longevity following IPG replacement is due to programming changes and whether there is an effect of IPG model.

Background: Although rechargeable batteries in deep brain stimulation are becoming more popular this is not always an option for all patients. We have shown that the rate of battery depletion increases with each successive IPG replacement which may be due to a combination of both harware and programme-related issues.

Methods: Seven patients with PD treated with bilateral STN-DBS with at least one Kinetra followed by an Activa PC were identified retrospectively. Their medical records were carefully reviewed and a measure of battery drain or treatment power was derived from their stimulation parameters after each visit according to the following equation: [Voltage] ^2⁄Impedance×pusle width×frequency. Impedance was estimated as 1000 Ω.

Results: As expected there was a negative correlation between predicted battery energy expenditure according to the equation above, r = -0.52, p<0.05, and battery life dropped with time in all cases but one.

Battery longevity and power of stimulation
  Longevity (months) – Power  
Patient IPG 1 IPG 2 IPG3 IPG4
P1 23.6 – 344 19.5 – 126    
P2 28.8 — 31.1 – 133 21.1 – 207  
P3 38.4 – 182 21.7 – 197    
P4 40.0 — 31.1 – 228 16.2 – 324  
P5 40.7 — 30.2 – 184 20.4 – 244 16.1 – 244
P6 41.0 – 163 29.3 – 126    
P7 43.1 – 107 28.0 – 77    
Battery life dropped by 11.8 ± 4.0 months after a replacement of a Kinetra with an Activa PC, p<0.001, paired t-test single tail) but there was no significant change in stimulation parameters according to the formula above, even when the patients with multiple groups (n=1) or interleaving programs were excluded (p=0.08).

Conclusions: From this in-depth case series it appears that stimulation parameters often increase over time thus increasing battery drain and decreasing longevity with each replacement. This may be due to changes in the electrode-brain interface over time, brain plasticity causing habituation or attempts to treat to worsening symptom due to disease progression. The effect of IPG model beyond the use of higher stimulation parameters can best be attributed to the increased programming options such as the use of interleaving programs or repeated group changes which have a detrimental effect on battery life.

To cite this abstract in AMA style:

S.D. Israeli-Korn, S. Tessler, G. Yahalom, S. Benizri, O.S. Cohen, C. Shabat, H. Strauss, N. Warmann-Alaluf, E. Stein, Z. Zibly, R. Spiegelman, S. Hassin, S. Hassin. Reduction in battery longevity for each subsequent implantable pulse generator (IPG) in patients with Parkinson’s disease (PD) treated with bilateral subthalamic nucleus deep brain stimulation (STN-DBS) may be due to both programming changes and IPG model – a case series [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/reduction-in-battery-longevity-for-each-subsequent-implantable-pulse-generator-ipg-in-patients-with-parkinsons-disease-pd-treated-with-bilateral-subthalamic-nucleus-deep-brain-stimulation-stn-db/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/reduction-in-battery-longevity-for-each-subsequent-implantable-pulse-generator-ipg-in-patients-with-parkinsons-disease-pd-treated-with-bilateral-subthalamic-nucleus-deep-brain-stimulation-stn-db/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley